Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non–small-cell lung cancer
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (5) , 1281-1289
- https://doi.org/10.1016/s0360-3016(01)01732-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Phase II Trial of Daily Low-dose Carboplatin and Thoracic Radiotherapy in Elderly Patients with Locally Advanced Non-small Cell Lung CancerJapanese Journal of Clinical Oncology, 2000
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 1999
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancerLung Cancer, 1995
- Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaLung Cancer, 1994
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992